Rafael Holdings Inc (RFL) USD0.01 B
Rafael Holdings, Inc. is a clinical-stage oncology pharmaceutical company. The Company is focused on developing and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. It also owns interests in certain commercial real estate assets. The Company conducts business as two operating segments, Pharmaceuticals and Real Estate.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.